1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1H-pyrazole derivatives S TNF-alpha and interleukin lowering agents for the treatment of inflammations

Details for Australian Patent Application No. 2003273295 (hide)

International Classifications

Event Publications

5 February 2004 Complete Application Filed

Priority application(s): 60/409,176 09.09.02 US

13 May 2004 Application Open to Public Inspection

Published as AU-B-2003273295

22 March 2007 Application Accepted

Published as AU-B-2003273295

4 October 2007 Standard Patent Sealed

1 November 2007 Amendment Made

The nature of the amendment is: Amend the invention title to read 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one derivatives as TNF-alpha and interleukin lowering agents for the treatment of inflammation 2004

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.